Keith Krehbiel lived with Parkinson’s disease for nearly 25 years before agreeing to try a brain implant that might alleviate ...

--Medtronic plc, the global leader in medical technology, today announced the first enrollment in ADAPT-PD, its trial evaluating the safety and efficacy of adaptive deep brain stimulation in ...

Medtronic has received approval from the US Food and Drug Administration (FDA) for BrainSense, its adaptive deep brain stimulation (aDBS) therapy for patients living with Parkinson’s disease.

Earlier this year, Medtronic received approval from European regulators for its adaptive deep brain simulation (aDBS) technology, which includes an implant that can dynamically adjust signals to ...

Medtronic's BrainSense aDBS personalizes Parkinson's therapy in real-time, minimizing manual adjustments for better symptom control. BrainSense Electrode Identifier speeds up initial DBS ...

(RTTNews) - Medical technology company Medtronic plc (MDT) announced Thursday the first enrollment in ADAPT-PD (Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease), its trial ...

Medtronic now expects BrainSense aDBS and BrainSense EI to be available in Europe in early 2025. The global neurological devices market was valued at $12.5bn in 2023 and is forecast to reach $20.9 ...

Medtronic plc reported that the first patient has been enrolled in the Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) study its trial evaluating the safety and ...

ADAPT-PD Global Study Designed to Demonstrate Safety & Efficacy of Automated Therapy Which Responds to Brain Signals in Parkinson's Disease Patients DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Medtronic ...

The FDA has approved Medtronic’s BrainSense adaptive deep brain stimulation (aDBS) system and BrainSense Electrode Identifier (EI) in patients with Parkinson disease (PD). ... Medtronic earns U.S. FDA ...

On Monday, the FDA approved Medtronic plc’s (NYSE:MDT) BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s disease. Deep ...